Search the Newsreel

Shanghai Fudan Zhangjiang Bio Pharmaceutical Ltd (SEHK:1349) Stock Profit Rebound Raises Durability Questions

PARADEEP Share Price Today - Paradeep Phosphates on NSE/BSE

Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket

Eton Pharmaceuticals (NASDAQ: ETON) saw its shares rise significantly in pre-market trading after reporting stronger-than-expected second-quarter financial results and providing an optimistic revenue guidance for FY26. The company exceeded analyst consensus estimates for both earnings per share and sales. The article also lists other …

Is Teva Pharmaceutical Industries (TEVA) A Bargain On Its TEV 408 Phase 2b Move?

Teva Pharmaceutical Industries (TEVA) has initiated a phase 2b trial for its anti IL-15 antibody TEV-'408 for nonsegmental vitiligo, following promising phase 1b results. This development, coupled with a significant 1-year share price return of 105.88%, has renewed investor interest. While the stock is …

Is BioMarin Pharmaceutical (BMRN) Still Cheap As 2026 Guidance Rises And Amicus Adds Growth?

BioMarin Pharmaceutical (BMRN) has updated its 2026 guidance and completed the Amicus acquisition, leading to increased attention on the stock. Despite strong short-term momentum and a "22% Undervalued" narrative, the article highlights the need for investors to consider inherent risks, such as reliance on …

ETFs Investing in Regeneron Pharmaceuticals, Inc. Stocks

This article provides a comprehensive list of Exchange Traded Funds (ETFs) that invest in Regeneron Pharmaceuticals, Inc. (RGO) stocks. The list, sorted by market value, details each fund's symbol, market value, weight of RGO stock, issuer, management style, focus, expense ratio, assets under management …

ANI Pharmaceuticals (ANIP) Could Be 34% Undervalued As Earnings And Guidance Hold

ANI Pharmaceuticals (ANIP) is currently in focus after reporting its Q2 and H1 2026 results and reaffirming its full-year net revenue outlook of $1,080 million to $1,140 million. Despite recent strong earnings, the stock has seen a short-term decline, though it shows significant long-term …

Phillips 66 (PSX) Posts Strong Q2 And Pipeline Plans, Is The Upside Already Priced In?

Phillips 66 reported strong Q2 2026 results with increased sales, revenue, and earnings, alongside progress on its US$5 billion Western Gateway Pipeline project. The company has seen significant share price appreciation, with a 95.47% total shareholder return over the past year. While some analysts …

Ionis Pharmaceuticals (IONS) Has A $92 Fair Value Narrative, Is The Stock A Bargain?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Ionis Pharmaceuticals (IONS) has drawn investor attention after recent share price moves, with the stock up over the past month but down over the past …

Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks

Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sector. Today we are looking at …

Sergey Brin Wants Google to Double Down on Gemini. What That Means for GOOGL Stock.

Alphabet's (GOOGL) Google co-founder Sergey Brin has urged its parent company to focus more on its proprietary LLM Gemini. The report also indicates that Google's executives have taken a more hands-on approach to directing its AI operations. Google has recently announced that its AI …

Photronics, Inc. (PLAB) Investors: September 4, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - Hagens Berman

Hagens Berman has initiated an investigation into Photronics, Inc. (PLAB) following a class action lawsuit alleging the company misled investors about the demand for its high-end integrated circuit (IC) photomask products. The lawsuit claims Photronics made false statements regarding robust global demand, while facing …

Ralph Lauren (RL) Stock May Be 5% Overvalued Despite Raised 2027 Outlook

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Ralph Lauren stock has delivered a very strong 269.9% return over the past five …

Alphabet Is Facing Thousands of Lawsuits. History Says This Is What May Happen

Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) has outperformed the broader market over the past year, but recent developments have halted the company's run. Alphabet's second-quarter results, released on July 22, spooked investors, as its free cash flow turned negative due to significant investments in artificial …

Eton Pharmaceuticals Stock Soars After Huge Q2 Beat And Target Hikes

Eton Pharmaceuticals (ETON) stock surged by 45.78% after reporting a significant Q2 beat, with non-GAAP EPS of $0.43 and revenue of $37.6M, driven by 99% year-over-year growth. The company also raised its 2026 revenue guidance to over $145M and adjusted EBITDA margin to at …

Alphabet Stock to $515: 3 Reasons the Bull Case Is Getting Stronger

Alphabet (Google) Image by Markus Mainka via Shutterstock Alphabet (GOOG) (GOOGL) stock has pulled back after a strong rally, with shares now trading about 16% below their 52-week high. However, at least one analyst has set a $515 price target for Alphabet stock, the …

Berkshire pads Delta, Alphabet stakes as Abel taps cash pile

Berkshire Hathaway, under CEO Greg Abel, increased its holdings in Delta Air Lines and Alphabet, making the latter its third-biggest holding. The company also repurchased its own stock and made significant new investments, including acquiring homebuilder Taylor Morrison Home Corp. and a $10 billion …

Earnings Release: Here's Why Analysts Cut Their Dolphin Entertainment, Inc. (NASDAQ:DLPN) Price Target To US$3.00

SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript

Eton Pharmaceuticals Soars After Blowout Q2 And Guidance Hike

Eton Pharmaceuticals (NASDAQ: ETON) experienced a significant stock surge of over 45% after reporting blowout Q2 earnings and raising its 2026 revenue guidance. The company's Q2 non-GAAP EPS and revenue significantly beat consensus estimates, driven by strong growth and the successful relaunch of Hemangeol. …

Will Aurinia’s Reaffirmed 2026 Guidance and Large Buyback Reshape Aurinia Pharmaceuticals' (AUPH) Narrative?

S&P 500, Nasdaq Close Lower On Tech Weakness But Recover After-Hours On Strong Micron Earnings — MU, AVGO, GOOGL In Focus

Acumen Pharmaceuticals Inc (ABOS) Stock News Today

Don't Ignore The Insider Selling In Rocket Pharmaceuticals

A Chief Operating Officer at Rocket Pharmaceuticals recently sold US$128k worth of shares, representing 6.8% of their holding. This sale was the largest insider sale in the past year, though it occurred around the current market price, making it less concerning than sales at …

PHINIA (PHIN) Could Be 19% Undervalued As Sustainability Report Sharpens Its Growth Story

PHINIA (PHIN) has released its third annual Sustainability Report, highlighting progress in ESG priorities and investments in lower/zero-carbon technologies. Despite recent share price cooling, a narrative suggests PHINIA is 19% undervalued with a fair value of $92, driven by its shift to diversified energy …

Sutro Biopharma, Inc. (NASDAQ:STRO) Just Reported And Analysts Have Been Lifting Their Price Targets

Insider Sale Alert: Triumph Financial EVP Nelson Sells 3,750 Shares

Adam D. Nelson, EVP and General Counsel of Triumph Financial (NYSE:TFIN), sold 3,750 shares on Aug. 4, 2026, according to a recent SEC Form 4 filing. Transaction summary Metric Value Transaction value $296,438 Shares sold 3,750 Post-transaction shares (directly held) 23,755 Post-transaction value $1.9 …

5 Insightful Analyst Questions From Ralph Lauren’s Q2 Earnings Call

5 Insightful Analyst Questions From Ralph Lauren's Q2 Earnings Call Ralph Lauren delivered a positive second quarter, highlighted by consistent double-digit growth across regions and heightened brand engagement. Management attributed the quarter's results to ongoing brand elevation, strong performance in Asia and North America, …

Berkshire adds $17 billion to Alphabet stake

Berkshire Hathaway significantly increased its stake in Alphabet (Google's parent company) by $17 billion in Q2, making it the third-largest holding in Berkshire's portfolio. Approximately $10 billion of this was a private placement purchase directly from Alphabet, with an additional $7 billion bought on …

Alphabet Counts the Ka-Ching With SpaceX Returns

Alphabet Counts the Ka-Ching With SpaceX Returns - Moby THE GIST Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. In 2015, Google …

Recursion Pharmaceuticals (RXRX) Stock Dropped, So What Is Behind The Move?

Xenon Pharmaceuticals Independent Director Steven Gannon Sells 84% Of Holding

Theravance Biopharma Deal Faces Investor Probe

Halper Sadeh LLC is investigating the proposed acquisition of Theravance Biopharma (NASDAQ: TBPH) by Zymeworks Inc. for $17 per share in cash plus a contingent value right. The investigation aims to determine if Theravance shareholders are receiving a fair price and if the company's …

Alphabet Is Berkshire Hathaway’s New Favorite Stock After Buying 48 Million Shares

Quick Read Greg Abel broke Berkshire's 14-quarter net-selling streak by buying 48 million Alphabet shares worth $37.8 billion in Q2. The purchase vaults Alphabet to Berkshire's third-largest holding at 10% of the portfolio, behind only Apple and American Express. Alphabet's search monopoly, 2.7 billion …

UpHealth Group H1 2026 Results: Post-Acquisition Revenue of S$29.96M, Net Loss Widens to S$4.79M, No Interim Dividend Declared – Minichart

Alphabet vs. Oracle: Which Is the Better AI Stock to Own for the Next 5 Years?

Cloud computing has become ground zero for artificial intelligence (AI) development. The large cloud infrastructure companies provide platforms where developers can create their AI apps, which is where the magic happens. Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) and Oracle (NYSE: ORCL) are the third- and …